DEVELOPMENT OF SIRNA NANOJACKETS FOR INFLUENZA TREATMENT
$224,881N43FY2015AINIH
Keystone Nano, Inc., State College PA
Investigators
Abstract
To develop broad spectrum anti-influenza treatments.
View original record on NIH RePORTER →Keystone Nano, Inc., State College PA
To develop broad spectrum anti-influenza treatments.
View original record on NIH RePORTER →